Skip to content
← Back to blogFDA Stories

FDA Stories #012 — Argan Oil: Assessing Food and Cosmetic Uses

An illustrative Moroccan argan-oil scenario explains intended use, current allergen scope and conditional food and MoCRA obligations.

Author:
FDABridge Team
Published:
Read time:
4 minutes

Source review: 5 October 2026. Editorial guidance; not FDA approval or a substitute for a product-specific assessment.

This is a hypothetical educational scenario, not a verified client engagement. The previous version described client actions and outcomes without substantiating records available for this review; those claims have been removed. No shipment outcome or exemption qualification is asserted.

Illustrative scenario: one oil, different intended uses

Consider an argan oil offered for cooking and also marketed for skin or hair care. Assess its intended uses from claims, advertising, directions and presentation. A food use and a cosmetic use can bring different requirements; therapeutic claims may additionally raise drug questions. The fact that the same oil can be used in different ways does not establish a universal legal requirement for two SKUs, two labels or two registrations. Separate product presentations may be a practical workflow, but each actual use and label must be assessed.

Food obligations are conditional

A site manufacturing, processing, packing or holding food for US consumption generally needs food-facility registration unless an exemption applies. Assess actual activities, including relevant foreign further-processing exemptions; a brand-only office is not automatically a registrable facility. A foreign facility requiring registration needs a US Agent and the accepted food UFI, currently DUNS. Food registration is separate from a cosmetic FEI.

Nutrition Facts is generally required for covered packaged food, but 21 CFR 101.9 contains conditional exemptions, including qualifying small-business/low-volume situations. Claims and other facts can defeat an exemption. This scenario supplies no sales, volume or claim evidence to establish one. Assess ordinary ingredient naming, identity, net quantity and other applicable food-label requirements independently.

Argan is not in FDA Edition 5 Table 1 of major tree-nut allergens. Do not assert that argan oil requires a major-tree-nut Contains declaration on that basis. Coconut and chestnut are likewise not major tree-nut allergens under the current guidance. Appropriate ordinary ingredient identification and applicable safety duties remain; another major-allergen ingredient or protein can still require disclosure. A non-major classification is not a guarantee against allergic reactions.

Cosmetic obligations are conditional

MoCRA facility registration and responsible-person product listing depend on the actual manufacturing activities, product and applicable exemptions. Certain qualifying small businesses are exempt from these two requirements, but the exemption does not cover the specified higher-risk categories, including products regularly contacting the eye’s mucous membrane, injected products, internal-use products and specified long-lasting appearance changes. Do not assume this hypothetical business qualifies; document the statutory sales/product criteria. Other drug/device-related exemptions can also need assessment. An exemption from registration/listing does not remove all applicable safety and labeling duties.

Where cosmetic registration applies, obtain FEI before filing and identify the appropriate foreign-facility US Agent. Cosmetic facility renewal is tied to that facility’s two-year registration anniversary; product-listing updates are annual. It is not the October–December food renewal calendar. FDA registration/listing is not cosmetic approval.

US retail cosmetic ingredient declarations generally use common or usual names under 21 CFR 701.3, in descending order subject to its exceptions. An INCI or Latin-only list is not automatically sufficient: FDA does not accept foreign alternatives such as Aqua or Parfum as substitutes for Water or Fragrance, though they can follow in parentheses. Confirm an appropriate US name for the actual argan ingredient rather than treating an international naming convention as blanket compliance.

Recommended classification and evidence record

For each presentation, record intended use and claims; responsible business; actual facility activities; applicability/exemption evidence; food versus cosmetic identifier; proposed artwork and US ingredient names; Nutrition Facts assessment; safety evidence; filing owner; unresolved questions and dated review. This is a recommended workflow, not an FDA form. Do not claim a completed filing or client outcome without records.

Illustrative next step: a culinary presentation needs its food obligations assessed; a topical presentation needs its cosmetic obligations assessed. Choosing separate labels can aid review but does not itself resolve every requirement. Request a defined service scope at https://fdabridge.com/contact . Cosmetic information: https://fdabridge.com/cosmetics .

For applicable food facilities, renewal is 1 October–31 December 2026; an earlier registration/update does not replace renewal. FDA’s food filing fee is zero; professional charges are separate. Label review is a separate task. Renewal guide: https://fdabridge.com/blog/fda-food-facility-registration-renewal-2026

Current allergen guide: https://fdabridge.com/blog/fda-allergen-labeling-nine-major-allergens-faster-act

Primary sources: FDA Edition 5 Table 1: https://www.fda.gov/media/117410/download

FDA cosmetic registration, listing and exemptions: https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products

FDA cosmetic ingredient names: https://www.fda.gov/cosmetics/cosmetics-labeling/cosmetic-ingredient-names

Nutrition labeling requirements and exemptions: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-A/section-101.9

FDA food-business applicability: https://www.fda.gov/food/food-industry/how-start-food-business